Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy

被引：22

作者：

Carr, A ^{[1
]}

机构：

[1] St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia

来源：

LANCET | 2002年 / 360卷 / 9326期

关键词：

D O I：

10.1016/S0140-6736(02)09341-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 85

页数：5

共 22 条

[1] The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].

Altman, DG ;

Schulz, KF ;

Moher, D ;

Egger, M ;

Davidoff, F ;

Elbourne, D ;

Gotzsche, PC ;

Lang, T .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694

[2] Predictors of protease inhibitor-associated adverse events [J].

Bonfanti, P ;

Ricci, E ;

Landonio, S ;

Valsecchi, L ;

Timillero, L ;

Faggion, I ;

Quirino, T .

BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (06) :321-323

[3] Adverse effects of antiretroviral therapy [J].

Carr, A ;

Cooper, DA .

LANCET, 2000, 356 (9239) :1423-1430

[4]

Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005

[5]

Clever L, 1997, NEW ENGL J MED, V336, P309

[6]

de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014

[7]

*EUR AG EV MED PRO, 2001, CPMPICH36396 EUR AG

[8]

*EUR AG EV MED PRO, 2001, CPMPICH37595 EUR AG

[9]

*EUR AG EV MED PRO, 2000, CPMPICH13795 EUR AG

[10]

*EUR AG EV MED PRO, 2001, CPMPICH2887 EUR AG E

← 1 2 3 →